Bupropion and Restless Legs Syndrome

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Restless Legs Syndrome

In brief

The purpose of this study is to determine if bupropion will improve the symptoms of restless legs syndrome (RLS).

Key facts

Study ID

NCT00621517

Run by

East Tennessee State University

People needed

60

Starts

2008-02-01

Expected to finish

2009-07-01

Last updated by the study team

2019-03-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• clinical diagnosis of Restless Legs Syndrome
• Severity Scale score 15 or higher

You may not qualify if…

• History of seizures
• History of alcohol use greater than 2 drinks per day or occasional binges of 5 or more drinks per day
• Suicidal thoughts/ideations
• Inability to return for follow up appointments at 3 and 6 weeks
• Lack of access to telephone
• Eating disorder
• Age less than 18
• Pregnancy
• Unwillingness or inability to discontinue any RLS medications

Where it is running

• East Tennessee State University — Johnson City, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.